Accendra Health Receives Continued Listing Standard Notice from NYSE; Intends to Cure Deficiency and Return to Compliance with NYSE Listing Standard
Business Wire•09/10/2026•16:05 ET
0
Key Highlights
- ➤NYSE notice: ACH averaged below $1.00 per share for 30 consecutive trading days
- ➤Six-month cure period gives Accendra Health until April 6, 2027, to regain compliance
- ➤Accendra Health may pursue a reverse stock split requiring shareholder approval by May 2027
- ➤ACH shares remain listed and trading on NYSE during the cure period
Accendra Health Receives Continued Listing Standard Notice from NYSE; Intends to Cure Deficiency and Return to Compliance with NYSE Listing Standard
Accendra Health, Inc. (NYSE: ACH) (the Company) today announced that on October 6, 2026, it received a notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) notifying the Company that it is not in compliance with the NYSE’s continued listing standards because the average closing price of the Company’s Class A Common Stock (the “Common Stock”) was less than $1.00 per share over a consecutive 30 trading-day period. The Notice does not result in the immediate delisting of the Company’s Common Stock from the NYSE.
Get started
Create a free account to read the full story.